Serum zonulin has been reported to be elevated in inflammatory and autoimmune disorders [e.g., type 1 diabetes, inflammatory bowel disease, ankylosing spondylitis (AS), and CD], and its levels correlate with the opening of tight junctions and increased intestinal permeability when zonulin production is dysregulated (117–119). This evidence concerns the gene HP and type 1 diabetes mellitus.